University of Buenos Aires
Nitroxyl is an inhibitor of human platelet function
Published in Biotech Law Weekly, November 11th, 2005
"There is a growing body of evidence on the role of nitric oxide (NO) in human platelet physiology regulation. Recently, interest has developed in the functional role of an alternative redox form of NO, namely HNO/NO-, because it is formed by a number of diverse biochemical reactions," wrote E. Bermejo and colleagues, University of Buenos Aires.
"The aim of the present study was to comparatively analyze the effect of HNO and NO on several functional parameters of human platelets. For this purpose, sodium trioxodinitrate (Angeli salt, AS) and sodium...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2005-11-11)
More Articles from Biotech Law Weekly
- Acon Laboratories, Inc.
CLIA waiver received for drugs of abuse tests - Acuity Medical
Macular degeneration device improves vision in 26% of treated eyes in trial - Aerie Pharmaceuticals, Inc.
Glaucoma therapy developer closes $21M series A financing - Amnis Corp.
Three issued patents cover firm's expansions - Avax Technologies, Inc.
M-Vax launched in Switzerland for the treatment of patients with stage III-IV melanoma - Bausch & Lomb
Medicare reimbursement terms for Retisert published - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
